Protective effect of Cnestis ferruginea and its active constituent on scopolamine-induced memory impairment in mice: A behavioral and biochemical study

References

• Agrawal R, Tyagi E, Saxena G, Nath C. (2009). Cholinergic influence on memory stages: A study on scopolamine amnesic mice. Indian J Pharmacol 41:192–6
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association (2006). Early-Onset Dementia: A National Challenge, a Future Crisis. Washington, DC: Alzheimer’s Association
   Google Scholar
• Alzheimer’s Association (2012). 2012 Alzheimer’s disease, facts and figures. Available from: www.alz.org/downloads/facts_figures_2012.pdf [last accessed 18 Jun 2012]
   Google Scholar
• Awasthi H, Tota S, Hanif K, et al. (2010). Protective effect of curcumin against intracerebral streptozotocin induced impairment in memory and cerebral blood flow. Life Sci 86:87–94
   PubMed Web of Science ®Google Scholar
• Banerjee T, Valacchi G, Ziboh VA, van der Vliet A. (2002). Inhibition of TNF-α-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-κB activation in A549 cells. Mol Cell Biochem 238:105–10
   PubMedGoogle Scholar
• Beatty WW, Butters N, Janowsky DS. (1986). Patterns of memory failure after scopolamine treatment: Implications for cholinergic hypotheses of dementia. Behav Neural Biol 45:196–211
   PubMedGoogle Scholar
• Blokland A. (1995). Acetylcholine: A neurotransmitter for learning and memory? Brain Res Rev 21:285–300
   PubMedGoogle Scholar
• Bores GM, Huger FP, Petko W, et al. (1996). Pharmacological evaluation of novel Alzheimer’s disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine. J Pharmacol Exp Ther 277:728–38
   PubMed Web of Science ®Google Scholar
• Citron M. (2010). Alzheimer’s disease: Strategies for disease modification. Nat Rev Drug Discov 9:387–98
   PubMed Web of Science ®Google Scholar
• Colado MI, O’Shea E, Granados R, et al. (1997). A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 121:827–33
   PubMed Web of Science ®Google Scholar
• Drachman DA, Leavitt J. (1974). Human memory and the cholinergic system: A relationship to aging? Arch Neurol 30:113–21
   PubMed Web of Science ®Google Scholar
• Dringen R. (2000). Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem 267:4903
   PubMedGoogle Scholar
• Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
   PubMed Web of Science ®Google Scholar
• El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EES. (2003). Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnesic dose of scopolamine. Pharmacol Biochem Behav 76:523–33
   Google Scholar
• Fan Y, Hu J, Li J, et al. (2005). Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 374:222–6
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GK. (1999). The cholinergic hypothesis of Alzheimer's disease: A review of progress. J Neurol Neurosurg Psychiatry 66:137–47
   PubMed Web of Science ®Google Scholar
• Giacobini E. (2002). Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’s disease. J Neural Transm Suppl 62:181–7
   Google Scholar
• Gilgun-Sherki Y, Melamed E, Offen D. (2002). Antioxidant treatment in Alzheimer’s disease: Current state. J Mol Neurosci 21:1–11
   Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–8
   PubMed Web of Science ®Google Scholar
• Guan ZZ, Zhang X, Ravid R, Nordberg A. (2000). Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer’s disease. J Neurochem 74:237–43
   PubMed Web of Science ®Google Scholar
• Hebert LE, Scherr PA, Bienias JL, et al. (2003). Alzheimer disease in the U.S. population: Prevalence estimates using the 2000 Census. Arch Neurol 60:1119–22
   PubMed Web of Science ®Google Scholar
• Hyman BT, Damasio H, Damasio AR, Van Hoesen GW. (1989). Alzheimer’s disease. Ann Rev Public Health 10:115–40
   PubMedGoogle Scholar
• Ishola IO, Agbaje OE, Narender T, et al. (2012). Bioactivity guided isolation of analgesic and anti-inflammatory constituents of Cnestis ferruginea Vahl ex DC (Connaraceae) root. J Ethnopharmacol 142:383–9
   PubMedGoogle Scholar
• Ishola IO, Akindele AJ, Adeyemi OO. (2011). Analgesic and anti-inflammatory activities of Cnestis ferruginea Vahl ex DC (Connaraceae) methanol root extract. J Ethnopharmacol 135:55–62
   PubMed Web of Science ®Google Scholar
• Ishola IO, Ashorobi RB. (2007). Anti-stress potential of aqueous root extract of Cnestis ferruginea. Int J Pharmacol 3:295–8
   Google Scholar
• Jeong EJ, Lee KY, Kim SH, et al. (2008). Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine treated mice. Eur J Pharmacol 588:78–84
   PubMed Web of Science ®Google Scholar
• Kang SS, Lee JY, Choi YK, et al. (2004). Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblastoma cells. Bioorg Med Chem Lett 14:2261–4
   PubMed Web of Science ®Google Scholar
• Kang SS, Lee JY, Choi YK, et al. (2005). Neuroprotective effects of naturally occurring biflavonoids. Bioorg Med Chem Lett 15:3588–91
   PubMed Web of Science ®Google Scholar
• Kopelman MD, Corn TH. (1988). Cholinergic ‘blockade’ as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 111:1079–110
   PubMed Web of Science ®Google Scholar
• Kulkarni KS, Kasture SB, Mengi SA. (2011). Efficacy study of Prunus amygdalus (almond) nuts in scopolamine-induced amnesia in rats. Indian J Pharmacol 42:168–73
   Google Scholar
• Levey AI. (1996). Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease. Proc Natl Acad Sci USA 93:13541–6
   PubMed Web of Science ®Google Scholar
• Lorenzini CA, Baldi E, Bucherelli C, et al. (1996). Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat’s passive avoidance response: A tetrodotoxin functional inactivation study. Brain Res 730:32–9
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
   PubMed Web of Science ®Google Scholar
• Marcus DL, Thomas C, Rodriquez C, et al. (1998). Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease. Exp Neurol 150:40–4
   PubMed Web of Science ®Google Scholar
• Markham KR, Sheppard C, Geiger H. (1987). 13C NMR studies on some naturally occurring amentoflavone and hinokiflavone biflavonoids. Phytochemistry 26:3335–7
   Web of Science ®Google Scholar
• Oke JM, Hamburger MO. (2002). Screening of some Nigerian medicinal plants for antioxidant activity using 2,2,diphenyl-picryl-hydrazyl radical. Afr J Biomed Res 5:77–9
   Google Scholar
• Riedel W, Hogervorst E, Leboux R, et al. (1995). Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacol (Berl) 122:158–68
   PubMed Web of Science ®Google Scholar
• Sharma D, Puri M, Tiwary AK, et al. (2010). Antiamnesic effect of stevioside in scopolamine-treated rats. Indian J Pharmacol 42:164–7
   PubMed Web of Science ®Google Scholar
• Sunderland T, Tariot PN, Cohen RM, et al. (1987). Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls: A dose-response study. Arch Gen Psychiatry 44:418–26
   PubMed Web of Science ®Google Scholar
• Taffe MA, Weed MR, Gold LH. (1999). Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res 8:203–12
   PubMedGoogle Scholar
• Tota S, Awasthi H, Kamat PK, et al. (2010). Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 209:73–9
   PubMed Web of Science ®Google Scholar
• Tota S, Kamat PK, Awasthi H, et al. (2009). Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 199:235–40
   PubMed Web of Science ®Google Scholar
• Tota S, Kamat PK, Shukla R, Nath C. (2011). Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 221:207–15
   PubMedGoogle Scholar
• Wang C, Smith RL. (1975). Lowry determination of protein in the presence of Triton X-100. Anal Biochem 63:414–17
   PubMed Web of Science ®Google Scholar
• Whitehouse PJ, Price DL, Struble RG, et al. (1982). Alzheimer’s disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237–39
   PubMed Web of Science ®Google Scholar
• WHO (2006). Traditional medicine. Available from http://www.who.int/mediacentre/factsheets/fs134/en/ [last accessed on 29 Oct 2011]
   Google Scholar
• Youdim KA, Spencer JP, Schroeter H, Rice-Evans C. (2002). Dietary flavonoids as potential neuroprotectants. Biol Chem 383:503–19
   PubMed Web of Science ®Google Scholar
• Zhang ZJ. (2004). Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 75:1659–99
   PubMed Web of Science ®Google Scholar